BioLife Solutions, Inc. Financing Receivable, after Allowance for Credit Loss
BioLife Solutions, Inc. (BLFS) had Financing Receivable, after Allowance for Credit Loss of $1.00 million as of 2019-12-31, per its 10-K filed 2020-05-15.
Discontinued › Balance Sheet › Assets
us-gaap:NotesReceivableNet · last filed 2020-05-15
- 2019-12-31: Financing Receivable, after Allowance for Credit Loss $1.00M.
| Period end | Financing Receivable, after Allowance for Credit Loss |
|---|---|
| 2019-12-31 | $1.00M 10-K · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |